Somnomed Ltd Asset Resilience Ratio

Latest as of December 2024: 24.67%

Somnomed Ltd asset resilience ratio. Somnomed Ltd (SOM) has an Asset Resilience Ratio of 24.67% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See SOM cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Liquid Assets

AU$18.50 Million
≈ $13.09 Million USD Cash + Short-term Investments

Total Assets

AU$74.99 Million
≈ $53.06 Million USD All company assets

Resilience Assessment

Good
Financial Resilience Level

Asset Resilience Ratio of Somnomed Ltd (2016–2024)

Asset resilience ratio of Somnomed Ltd from 2016 to 2024. This chart shows how Somnomed Ltd's Asset Resilience Ratio has changed over time. Read debt load of Somnomed Ltd for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Somnomed Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see SOM current and non-current assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents AU$18.50 Million 24.67%
Short-term Investments AU$0.00 0%
Total Liquid Assets AU$18.50 Million 24.67%

Asset Resilience Insights

  • Good Liquidity Position: Somnomed Ltd maintains a healthy 24.67% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Somnomed Ltd Industry Peers by Asset Resilience Ratio

Compare Somnomed Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Shenzhen New Industries Biomedical
SHE:300832
Medical Devices 9.95%
Double Medical Technology Inc
SHE:002901
Medical Devices 12.59%
BMC Medical Co. Ltd. A
SHE:301367
Medical Devices 44.96%
Emvision Medical Devices Ltd
AU:EMV
Medical Devices 0.06%
Hironic Co. Ltd
KQ:149980
Medical Devices 17.42%
DRGEM Corporation
KQ:263690
Medical Devices 2.12%
Oncosil Medical Ltd
AU:OSL
Medical Devices 0.00%
Adherium Ltd
AU:ADR
Medical Devices 15.45%

Somnomed Ltd Asset Resilience Ratio by Year (2016–2024)

Somnomed Ltd asset resilience ratio by year from 2016 to 2024. The table below shows the annual Asset Resilience Ratio data for Somnomed Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-06-30 23.18% AU$16.18 Million
≈ $11.45 Million
AU$69.80 Million
≈ $49.39 Million
+4.04pp
2023-06-30 19.13% AU$11.96 Million
≈ $8.46 Million
AU$62.49 Million
≈ $44.22 Million
-7.80pp
2022-06-30 26.93% AU$15.64 Million
≈ $11.07 Million
AU$58.09 Million
≈ $41.10 Million
-10.65pp
2021-06-30 37.58% AU$21.11 Million
≈ $14.94 Million
AU$56.17 Million
≈ $39.74 Million
-11.33pp
2020-06-30 48.91% AU$30.17 Million
≈ $21.35 Million
AU$61.69 Million
≈ $43.65 Million
+26.76pp
2019-06-30 22.15% AU$7.70 Million
≈ $5.45 Million
AU$34.75 Million
≈ $24.59 Million
-7.14pp
2018-06-30 29.29% AU$13.38 Million
≈ $9.47 Million
AU$45.70 Million
≈ $32.33 Million
-5.19pp
2017-06-30 34.48% AU$14.21 Million
≈ $10.05 Million
AU$41.21 Million
≈ $29.16 Million
--
2016-06-30 0.00% AU$0.00
≈ $0.00
AU$40.43 Million
≈ $28.60 Million
--
pp = percentage points

About Somnomed Ltd

AU:SOM Australia Medical Devices
Market Cap
$46.50 Million
AU$65.72 Million AUD
Market Cap Rank
#21973 Global
#760 in Australia
Share Price
AU$0.30
Change (1 day)
+3.45%
52-Week Range
AU$0.24 - AU$0.82
All Time High
AU$3.28
About

SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. It provides SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product desig… Read more